Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT MeetingNasdaq"As a leader in gene therapy for MPS IIIA patients, we feel encouraged by the strong data demonstrated thus far in this trial, showin… Continue reading
New Gene Therapy Company To Focus On Lentiviral PlatformsPharmaceutical ProcessingBiotech company Vectalys has merged with FlashCell, a developer of non-integrating lentiviral delivered RNA treatments, to form Flash Therapeutics, a new privately held c… Continue reading
Homology Medicines Presents Data from PKU Gene Therapy Program Demonstrating Long-Term Durability of …PR Newswire (press release)BEDFORD, Mass., May 18, 2018 /PRNewswire/ — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announ… Continue reading
Macon DailyuniQure Presents Preclinical Data Demonstrating Advances in the Distribution of Gene TherapyNasdaqPreclinical Data Presented at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting in Chicago –. LEXINGTON, Mass. and … Continue reading
uniQure Presents Preclinical Data Demonstrating Advances in the …GlobeNewswire (press release)… — Preclinical Data Presented at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting in Chicago –. LEXINGTON, Mass. and AMSTERDAM,&n… Continue reading
Immuno-Oncology NewsEli Lilly Acquires Pegilodecakin, Potential Immunotherapy Now in Phase 3 TrialImmuno-Oncology NewsEli Lilly announced that it is acquiring ARMO BioSciences and its lead treatment candidate pegilodecakin (AM0010), an investigational … Continue reading
The ColumnistSynthetic Biology Tools Sales Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018Expert ConsultingThis report studies the global Synthetic Biology Tools market status and forecast, categorizes the global Synthe… Continue reading
Economic TimesStempeutics partners with Cipla for its stem cell drugEconomic TimesNEW DELHI: Biotech firm Stempeutics Research today said it has inked an out-licensing deal with drug major Cipla for its stem cell therapy product Stempeucel, indicated f… Continue reading